The Disease Prevention & Control Summit is the largest, most established meeting dedicated to combating infectious disease.
From cutting-edge research to policy implementation and commercial solutions, this one meeting covers the entire value chain, bringing together scientists, government officials, and industry leaders to drive groundbreaking progress in the fight against infectious disease.
Infection Control & Prevention
Focuses on innovative strategies and best practices to prevent and control infections, bringing together healthcare professionals, researchers, and policymakers to reduce the spread of antimicrobial resistance.
One-Health
Emphasizes the interconnectedness of human, animal, and environmental health in combating antimicrobial resistance, fostering collaboration across disciplines to develop comprehensive, sustainable solutions.
Manufacturing & Environment
Addresses the intersection of antibiotic production and environmental impact, bringing together experts to develop sustainable manufacturing practices that minimize ecological harm and reduce the spread of resistance.
Antimicrobial Stewardship
Focuses on best practices and strategies for the responsible use of antimicrobials, uniting healthcare professionals and policymakers to promote effective stewardship programs and curb resistance.
Antibiotic R&D
Focuses on the latest advancements in antibiotic research and development, uniting experts from academia, industry, and government to accelerate the discovery and deployment of innovative treatments against resistant pathogens.
Diagnostics
Highlights cutting-edge technologies and strategies for rapid, accurate detection of antimicrobial resistance, bringing together leading researchers, clinicians, and industry innovators to enhance diagnostic capabilities and improve patient outcomes.
Vaccines
Explores advancements in vaccine development against antimicrobial-resistant pathogens, uniting scientists, policymakers, and industry leaders to foster new approaches and strategies in combating resistance through immunization.
Genomics & Surveillance
Delves into the latest advancements in genomic technologies and surveillance systems, bringing together experts to enhance our understanding and monitoring of antimicrobial resistance patterns worldwide.
Antibiotic Commercialization
Explores the challenges and opportunities in bringing new antibiotics to market, connecting industry leaders, investors, and policymakers to drive the development and accessibility of novel treatments.
Innovation Showcase
Highlights groundbreaking technologies and solutions in the fight against antimicrobial resistance, providing a platform for innovators to present their cutting-edge developments and collaborate with global leaders in the field.